Publications by authors named "Andre Robidoux"

Claim this Profile
I
Impact of the 21-Gene Recurrence Score Assay on Treatment Decisions and Cost in Patients with Node-Positive Breast Cancer: A Multicenter Study in Quebec.
Saima Hassan, Rami Younan, Erica Patocskai, Louise Provencher, Brigitte Poirier, André Robidoux

Oncologist· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Definitive results of a phase III adjuvant trial comparing six cycles of FEC-100 to four cycles of AC in women with operable node-negative breast cancer: the NSABP B-36 trial (NRG Oncology).
Charles E Geyer, Hanna Bandos, Priya Rastogi, Samuel A Jacobs, André Robidoux

Breast Cancer Res Treat· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Definitive results of a phase III adjuvant trial comparing six cycles of FEC-100 to four cycles of AC in women with operable node-negative breast cancer: the NSABP B-36 trial (NRG Oncology).
Charles E Geyer, Hanna Bandos, Priya Rastogi, Samuel A Jacobs, André Robidoux

Breast Cancer Res Treat· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Behavioral and health outcomes from the NRG Oncology/NSABP B-36 trial comparing two different adjuvant therapy regimens for early-stage node-negative breast cancer.
Patricia A Ganz, Hanna Bandos, Charles E Geyer, André Robidoux, Alexander H G Paterson

Breast Cancer Res Treat· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Amplification and Adjuvant Clodronate Outcomes in Early-Stage Breast Cancer in NSABP B-34 and Potential Impact on Clinical Practice.
Alexander H G Paterson, Peter C Lucas, Stewart J Anderson, Eleftherios P Mamounas, Adam Brufsky, André Robidoux

JNCI Cancer Spectr· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic and predictive value of circulating tumor DNA during neoadjuvant chemotherapy for triple negative breast cancer.
Luca Cavallone, Adriana Aguilar-Mahecha, Josiane Lafleur, Susie Brousse, Mohammed Aldamry, André Robidoux

Sci Rep· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NSABP B-41, a Randomized Neoadjuvant Trial: Genes and Signatures Associated with Pathologic Complete Response.
Sandra M Swain, Gong Tang, Heather Ann Brauer, David S Goerlitz, Peter C Lucas, André Robidoux

Clin Cancer Res· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Wage losses among spouses of women with nonmetastatic breast cancer.
Brittany Humphries, Sophie Lauzier, Mélanie Drolet, Douglas Coyle, Benoît Mâsse, André Robidoux

Cancer· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NSABP B-47/NRG Oncology Phase III Randomized Trial Comparing Adjuvant Chemotherapy With or Without Trastuzumab in High-Risk Invasive Breast Cancer Negative for HER2 by FISH and With IHC 1+ or 2.
Louis Fehrenbacher, Reena S Cecchini, Charles E Geyer, Priya Rastogi, Joseph P Costantino, André Robidoux

J Clin Oncol· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The LISA randomized trial of a weight loss intervention in postmenopausal breast cancer.
Pamela J Goodwin, Roanne J Segal, Michael Vallis, Jennifer A Ligibel, Gregory R Pond, André Robidoux

NPJ Breast Cancer· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: NSABP FB-7: a phase II randomized neoadjuvant trial with paclitaxel + trastuzumab and/or neratinib followed by chemotherapy and postoperative trastuzumab in HER2+ breast cancer.
Samuel A Jacobs, André Robidoux, Jame Abraham, José Manuel Pérez-Garcia, Nicla La Verde

Breast Cancer Res· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Unique Morphological Phenotype in Chemoresistant Triple-Negative Breast Cancer Reveals Metabolic Reprogramming and PLIN4 Expression as a Molecular Vulnerability.
Isabelle Sirois, Adriana Aguilar-Mahecha, Josiane Lafleur, Emma Fowler, Viet Vu, André Robidoux

Mol Cancer Res· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Axillary Lymph Node Ultrasound Following Neoadjuvant Chemotherapy in Biopsy-Proven Node-Positive Breast Cancer: Results from the SN FNAC Study.
Dominique Morency, Sinziana Dumitra, Elena Parvez, Karyne Martel, Mark Basik, André Robidoux

Ann Surg Oncol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NSABP FB-7: a phase II randomized neoadjuvant trial with paclitaxel + trastuzumab and/or neratinib followed by chemotherapy and postoperative trastuzumab in HER2 breast cancer.
Samuel A Jacobs, André Robidoux, Jame Abraham, José Manuel Pérez-Garcia, Nicla La Verde

Breast Cancer Res· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pathologic complete response and outcomes by intrinsic subtypes in NSABP B-41, a randomized neoadjuvant trial of chemotherapy with trastuzumab, lapatinib, or the combination.
Sandra M Swain, Gong Tang, Peter C Lucas, André Robidoux, David Goerlitz

Breast Cancer Res Treat· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized Phase II Study Evaluating Palbociclib in Addition to Letrozole as Neoadjuvant Therapy in Estrogen Receptor-Positive Early Breast Cancer: PALLET Trial.
Stephen Johnston, Shannon Puhalla, Duncan Wheatley, Alistair Ring, Peter Barry, André Robidoux

J Clin Oncol· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum: Re: Using the 21-gene assay from core needle biopsies to choose neoadjuvant therapy for breast cancer: A multicenter trial. Journal of Surgical Oncology 2017;115(8):917-923.
Harry D Bear, Wen Wan, André Robidoux, Peter Rubin, Steven Limentani

J Surg Oncol· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Chemotherapy for ER-Negative and ER-Positive Isolated Locoregional Recurrence of Breast Cancer: Final Analysis of the CALOR Trial.
Irene L Wapnir, Karen N Price, Stewart J Anderson, André Robidoux, Miguel Martín

J Clin Oncol· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The identification of challenges in tissue collection for biomarker studies: the Q-CROC-03 neoadjuvant breast cancer translational trial experience.
Adriana Aguilar-Mahecha, Josiane Lafleur, Manuela Pelmus, Carole Seguin, Cathy Lan, André Robidoux

Mod Pathol· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative Evaluation of Iodine-125 Radioactive Seed Localization and Wire Localization for Resection of Breast Lesions.
Vi Thuy Tran, Julie David, Erica Patocskai, Mathieu Zummo-Soucy, Rami Younan, André Robidoux

Can Assoc Radiol J· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Effect on Surgical Complications of Bevacizumab Added to Neoadjuvant Chemotherapy for Breast Cancer: NRG Oncology/NSABP Protocol B-40.
Harry D Bear, Gong Tang, Priya Rastogi, Charles E Geyer, Christine K Zoon, André Robidoux

Ann Surg Oncol· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Using the 21-gene assay from core needle biopsies to choose neoadjuvant therapy for breast cancer: A multicenter trial.
Harry D Bear, Wen Wan, André Robidoux, Peter Rubin, Steven Limentani

J Surg Oncol· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Limitations of Personalized Medicine and Gene Assays for Breast Cancer.
David Tiberi, Laura Masucci, Daniel Shedid, Isabelle Roy, Toni Vu, André Robidoux

Cureus· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Poor Prognosis After Second Locoregional Recurrences in the CALOR Trial.
Irene L Wapnir, Shari Gelber, Stewart J Anderson, Eleftherios P Mamounas, André Robidoux

Ann Surg Oncol· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epirubicin With Cyclophosphamide Followed by Docetaxel With Trastuzumab and Bevacizumab as Neoadjuvant Therapy for HER2-Positive Locally Advanced Breast Cancer or as Adjuvant Therapy for HER2-Positive Pathologic Stage III Breast Cancer: A Phase II Trial of the NSABP Foundation Research Group, FB-5.
John W Smith, Marc E Buyse, Priya Rastogi, Charles E Geyer, Samuel A Jacobs, André Robidoux

Clin Breast Cancer· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis